NO20050888D0 - Ny fremgangsmate for syntesen av 1,3,4,5-tetrahydro-2H-3-benzazepin-2-onforbindelser, og anvendelse i syntesen av ivabradin og addisjonssalter derav med en farmasoytisk akseptabel syre - Google Patents

Ny fremgangsmate for syntesen av 1,3,4,5-tetrahydro-2H-3-benzazepin-2-onforbindelser, og anvendelse i syntesen av ivabradin og addisjonssalter derav med en farmasoytisk akseptabel syre

Info

Publication number: NO20050888D0
Authority: NO; Norway
Prior art keywords: synthesis; ivabradine; benzazepin; tetrahydro; compounds
Prior art date: 2004-04-13

Application number

NO20050888A

Other languages

English (en)

Other versions

NO329861B1 (no

NO20050888L (no

Inventor

Jean-Pierre Lecouve

Jean-Claude Souvie

Daniel Brigot

Jean-Michel Lerestif

Original Assignee

Servier Lab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-04-13

Filing date

2005-02-18

Publication date

2005-02-18

2005-02-18 Application filed by Servier Lab filed Critical Servier Lab

2005-02-18 Publication of NO20050888D0 publication Critical patent/NO20050888D0/no

2005-10-14 Publication of NO20050888L publication Critical patent/NO20050888L/no

2011-01-17 Publication of NO329861B1 publication Critical patent/NO329861B1/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/16—Benzazepines; Hydrogenated benzazepines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Cardiology (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Heart & Thoracic Surgery (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
Hospice & Palliative Care (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Other In-Based Heterocyclic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

NO20050888A 2004-04-13 2005-02-18 Ny fremgangsmate for syntesen av 1,3,4,5-tetrahydro-2H-3-benzazepin-2-onforbindelser, og anvendelse i syntesen av ivabradin og addisjonssalter derav med en farmasoytisk akseptabel syre NO329861B1 (no)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR0403828A FR2868775B1 (fr)	2004-04-13	2004-04-13	Nouveau procede de synthese de derives de la 1,3,4,5- tetrahydro-2h-3-benzazepin-2-one, et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable

Publications (3)

Publication Number	Publication Date
NO20050888D0 true NO20050888D0 (no)	2005-02-18
NO20050888L NO20050888L (no)	2005-10-14
NO329861B1 NO329861B1 (no)	2011-01-17

Family

ID=34941961

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20050888A NO329861B1 (no)	2004-04-13	2005-02-18	Ny fremgangsmate for syntesen av 1,3,4,5-tetrahydro-2H-3-benzazepin-2-onforbindelser, og anvendelse i syntesen av ivabradin og addisjonssalter derav med en farmasoytisk akseptabel syre

Country Status (32)

Country	Link
US (1)	US7064200B2 (no)
EP (1)	EP1614687B1 (no)
JP (2)	JP4515933B2 (no)
KR (1)	KR100636499B1 (no)
CN (1)	CN100348585C (no)
AR (1)	AR047707A1 (no)
AT (1)	ATE448221T1 (no)
AU (1)	AU2005200884B2 (no)
BR (1)	BRPI0500590B8 (no)
CA (1)	CA2496712C (no)
CY (1)	CY1109740T1 (no)
DE (1)	DE602005017541D1 (no)
DK (1)	DK1614687T3 (no)
EA (1)	EA007743B1 (no)
EG (1)	EG25619A (no)
ES (1)	ES2336461T3 (no)
FR (1)	FR2868775B1 (no)
GE (1)	GEP20074136B (no)
HR (1)	HRP20100024T1 (no)
MA (1)	MA27598A1 (no)
MX (1)	MXPA05003696A (no)
MY (1)	MY140904A (no)
NO (1)	NO329861B1 (no)
NZ (1)	NZ538328A (no)
PL (1)	PL1614687T3 (no)
PT (1)	PT1614687E (no)
RS (1)	RS51232B (no)
SG (1)	SG116574A1 (no)
SI (1)	SI1614687T1 (no)
UA (1)	UA81773C2 (no)
WO (1)	WO2005111027A1 (no)
ZA (1)	ZA200501468B (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2868777B1 (fr) *	2004-04-13	2006-05-26	Servier Lab	Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
FR2868775B1 (fr) *	2004-04-13	2008-04-11	Servier Lab	Nouveau procede de synthese de derives de la 1,3,4,5- tetrahydro-2h-3-benzazepin-2-one, et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
GT200500185A (es) *	2004-08-09	2006-04-10		Moduladores del receptor de progesterona que comprenden derivados de pirrol-oxindol y sus usos
RU2473544C2 (ru)	2007-05-30	2013-01-27	Инд-Свифт Лабораториз Лимитед	Способ получения ивабрадина гидрохлорида и его полиморфных модификаций
CN102264689B (zh)	2008-12-22	2014-12-31	新梅斯托克尔卡公司	制备伊伐布雷定的方法
FR2940287B1 (fr) *	2008-12-24	2010-12-24	Servier Lab	Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable.
SI2902384T1 (en)	2010-02-12	2018-03-30	Krka, D.D., Novo Mesto	The form of ivabradine hydrochloride
FR2956401B1 (fr) *	2010-02-17	2012-02-03	Servier Lab	Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
FR2971507B1 (fr) *	2011-02-14	2013-01-18	Servier Lab	Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
FR2984320B1 (fr) *	2011-12-20	2013-11-29	Servier Lab	Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
FR2993561B1 (fr) *	2012-07-17	2014-10-31	Servier Lab	Procede de synthese enzymatique de la (7s)-1-(3,4-dimethoxy bicyclo[4.2.0]octa-1,3,5-triene 7-yl) n-methyl methanamine, et application a la synthese de l'ivabradine et de ses sels
FR3003859B1 (fr) *	2013-03-26	2015-03-13	Servier Lab	"procede de synthese de derives de la 7,8-dimethoxy-1,3-dihydro-2h-3-benzazepin-2-one et application a la synthese de l'ivabradine"

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3119874A1 (de) *	1981-05-19	1982-12-09	Dr. Karl Thomae Gmbh, 7950 Biberach	"benzazepinderivate, ihre herstellung und ihre verwendung als arzneimittel"
DE3418270A1 (de) *	1984-05-17	1985-11-21	Dr. Karl Thomae Gmbh, 7950 Biberach	Neue aminotetralinderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
EP0204349A3 (de) *	1985-06-01	1990-01-03	Dr. Karl Thomae GmbH	Neue heteroaromatische Aminderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
DE3519735A1 (de) *	1985-06-01	1986-12-04	Dr. Karl Thomae Gmbh, 7950 Biberach	Neue heteroaromatische aminderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
FR2681862B1 (fr) *	1991-09-27	1993-11-12	Adir Cie	Nouvelles (benzocycloalkyl)alkylamines, leur procede de preparation, et les compositions pharmaceutiques qui les contiennent.
FR2868777B1 (fr) *	2004-04-13	2006-05-26	Servier Lab	Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
FR2868775B1 (fr) *	2004-04-13	2008-04-11	Servier Lab	Nouveau procede de synthese de derives de la 1,3,4,5- tetrahydro-2h-3-benzazepin-2-one, et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable

2004
- 2004-04-13 FR FR0403828A patent/FR2868775B1/fr not_active Expired - Fee Related
2005
- 2005-02-07 CA CA2496712A patent/CA2496712C/fr not_active Expired - Lifetime
- 2005-02-15 SG SG200500770A patent/SG116574A1/en unknown
- 2005-02-17 US US11/060,043 patent/US7064200B2/en not_active Expired - Lifetime
- 2005-02-18 MY MYPI20050621A patent/MY140904A/en unknown
- 2005-02-18 NO NO20050888A patent/NO329861B1/no unknown
- 2005-02-18 ZA ZA2005/01468A patent/ZA200501468B/en unknown
- 2005-02-18 AR ARP050100586A patent/AR047707A1/es active IP Right Grant
- 2005-02-18 JP JP2005041810A patent/JP4515933B2/ja not_active Expired - Lifetime
- 2005-02-18 NZ NZ538328A patent/NZ538328A/en not_active IP Right Cessation
- 2005-02-18 MA MA28112A patent/MA27598A1/fr unknown
- 2005-02-18 UA UAA200501524A patent/UA81773C2/uk unknown
- 2005-02-18 BR BRPI0500590A patent/BRPI0500590B8/pt not_active IP Right Cessation
- 2005-02-18 CN CNB2005100542167A patent/CN100348585C/zh not_active Expired - Lifetime
- 2005-02-18 AU AU2005200884A patent/AU2005200884B2/en not_active Expired
- 2005-02-18 GE GEAP8647A patent/GEP20074136B/en unknown
- 2005-02-19 EG EG2005020086A patent/EG25619A/xx active
- 2005-02-19 KR KR1020050013860A patent/KR100636499B1/ko not_active Expired - Lifetime
- 2005-02-21 SI SI200530864T patent/SI1614687T1/sl unknown
- 2005-02-21 ES ES05290383T patent/ES2336461T3/es not_active Expired - Lifetime
- 2005-02-21 WO PCT/FR2005/000396 patent/WO2005111027A1/fr not_active Ceased
- 2005-02-21 AT AT05290383T patent/ATE448221T1/de active
- 2005-02-21 RS RSP-2010/0006A patent/RS51232B/sr unknown
- 2005-02-21 DE DE602005017541T patent/DE602005017541D1/de not_active Expired - Lifetime
- 2005-02-21 DK DK05290383.8T patent/DK1614687T3/da active
- 2005-02-21 EP EP05290383A patent/EP1614687B1/fr not_active Expired - Lifetime
- 2005-02-21 PT PT05290383T patent/PT1614687E/pt unknown
- 2005-02-21 EA EA200500240A patent/EA007743B1/ru unknown
- 2005-02-21 PL PL05290383T patent/PL1614687T3/pl unknown
- 2005-04-07 MX MXPA05003696A patent/MXPA05003696A/es active IP Right Grant
2009
- 2009-09-25 JP JP2009220529A patent/JP5277130B2/ja not_active Expired - Lifetime
2010
- 2010-01-13 HR HR20100024T patent/HRP20100024T1/hr unknown
- 2010-01-19 CY CY20101100053T patent/CY1109740T1/el unknown

Also Published As

Publication number	Publication date
JP4515933B2 (ja)	2010-08-04
WO2005111027A1 (fr)	2005-11-24
CA2496712C (fr)	2010-04-06
ZA200501468B (en)	2005-11-30
EP1614687B1 (fr)	2009-11-11
CN100348585C (zh)	2007-11-14
ES2336461T3 (es)	2010-04-13
PL1614687T3 (pl)	2010-04-30
EA200500240A1 (ru)	2005-10-27
AU2005200884A1 (en)	2005-10-27
SI1614687T1 (sl)	2010-01-29
MY140904A (en)	2010-01-29
NO329861B1 (no)	2011-01-17
GEP20074136B (en)	2007-06-25
FR2868775B1 (fr)	2008-04-11
DK1614687T3 (da)	2010-03-29
HK1079777A1 (zh)	2006-04-13
NO20050888L (no)	2005-10-14
BRPI0500590B8 (pt)	2021-05-25
KR20060042117A (ko)	2006-05-12
JP2010047577A (ja)	2010-03-04
AR047707A1 (es)	2006-02-08
DE602005017541D1 (de)	2009-12-24
CY1109740T1 (el)	2014-09-10
JP2005298478A (ja)	2005-10-27
RS51232B (sr)	2010-12-31
SG116574A1 (en)	2005-11-28
HRP20100024T1 (hr)	2010-02-28
AU2005200884B2 (en)	2010-07-15
CN1683343A (zh)	2005-10-19
US7064200B2 (en)	2006-06-20
EP1614687A1 (fr)	2006-01-11
CA2496712A1 (fr)	2005-10-13
US20050228178A1 (en)	2005-10-13
FR2868775A1 (fr)	2005-10-14
JP5277130B2 (ja)	2013-08-28
PT1614687E (pt)	2009-12-02
EA007743B1 (ru)	2006-12-29
ATE448221T1 (de)	2009-11-15
MXPA05003696A (es)	2006-01-24
EG25619A (en)	2012-03-26
UA81773C2 (uk)	2008-02-11
MA27598A1 (fr)	2005-11-01
BRPI0500590B1 (pt)	2018-10-09
KR100636499B1 (ko)	2006-10-18
BRPI0500590A (pt)	2005-11-16
NZ538328A (en)	2005-10-28

Publication	Publication Date	Title
NO20050884D0 (no)	2005-02-18	Ny fremgangsmate for syntesen av ivabradin og addisjonssalter derav med en farmasoytisk akseptabel syre
NO20050883D0 (no)	2005-02-18	Ny fremgangsmate for syntesen (IS)-4,5-dimetoksy-1-(metylaminometyl)-benzocyklobutan og addisjonssalter derav, og anvendelse i syntesen av ivabradin og addisjonssalter derav med en farmasoytisk akseptabel syre
ZA200904316B (en)	2010-05-26	Process for the synthesis of 7,8-dimethoxy-1,3-dihydro-2H-3-benzazepin-2-one, and application in the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
EE05032B1 (et)	2008-06-16	Meetod perindopriili ja selle farmatseutiliselt sobivate soolade snteesimiseks
NO20050888L (no)	2005-10-14	Ny fremgangsmate for syntesen av 1,3,4,5-tetrahydro-2H-3-benzazepin-2-onforbindelser, og anvendelse i syntesen av ivabradin og addisjonssalter derav med en farmasoytisk akseptabel syre
PT1876169E (pt)	2016-03-21	Derivados n-acilo contendo fenilo de amina e aminoácido, métodos para a sua produção, uma composição farmacêutica e a sua utiliza-ção
PL1631296T3 (pl)	2007-08-31	Pochodne amidu kwasu 2,3,4,5,-tetrahydrobenzo[f][1,4]oksazepino-5-karboksylowego jako inhibitory gamma-sekretazy do leczenia choroby Alzheimera
ZA200501467B (en)	2005-11-30	Process for the synthesis of 1,3-dihydro-2h-3-benzazepin-2-one compounds, and application in the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
ZA200510324B (en)	2007-03-28	Novel method for the synthesis of perindopril and the pharmaceutically acceptable salts thereof
EP1587792A4 (en)	2011-03-09	STABLE, AMORPHOUS AMLODIPINE CAMSYLATE, METHOD FOR PREPARING THE SAME AND COMPOSITION FOR ORAL ADMINISTRATION
SI1403275T1 (sl)	2006-02-28	Nov postopek sinteze perindoprila in njegovih farmacevtsko sprejemljivih soli
PL379625A1 (pl)	2006-10-30	Nowy sposób syntezy perindoprilu i jego farmaceutycznie dopuszczalnych soli
PL379631A1 (pl)	2006-10-30	Nowy sposób syntezy perindoprilu i jego farmaceutycznie dopuszczalnych soli
ZA200601300B (en)	2007-03-28	Novel n-substituted indolyl-3-glyoxylic acid amides, use thereof as a medicament, and method for the production thereof
WO2005046677A3 (en)	2005-08-04	At1-receptor antagonists for treating nephrotic syndrome
WO2008005955A3 (en)	2008-10-09	Synthesis of heterocyclic compounds
JO2518B1 (en)	2010-03-17	A new method for the combination of ivabradine and its added salts with pharmaceutically acceptable acid
IL175282A0 (en)	2006-09-05	Preparation of pharmaceutical salts of [1,4]-bipiperidine